When Big Pharma Pays a Publisher to Publish a Fake Journals...
Respectful Insolence, Orac, May 4, 2009.

We cover the relative trustworthiness of open access journals here from time to time, and the presumption is always that traditional publishers are reliable, authoritative. I have always railed against that suggestion, because I don't believe they are more trustworthy at all. Here is evidence showing that big publishers are, in some ways, manifestly untrustworthy: "on Thursday, it was revealed that pharmaceutical company Merck, Sharp & Dohme paid Elsevier to produce a fake medical journal that, to any superficial examination, looked like a real medical journal but was in reality nothing more than advertising for Merck." Commercial publishers don't care about science, they care about profit. See also Crooked Timber on astroturf journals, along with Bioethics on the phony journal scandal and TechDirt on Elsevier Exposed.
(Hits Today: 0 Total: 550) [Direct Link] [Tags: Books, Marketing, Open Access]

Share |

Comments

Comment



Title
Your comment:
Enter email to receive replies:

Your comments always remain your property, but in posting them here you agree to license under the same terms as this site (CC By-NC-SA). If your comment is offensive it will be deleted.

Automated Spam-checking is in effect. If you are a registered user you may submit links and other HTML. Anonymous users cannot post links and will have their content screened - certain words are prohibited and your comment will be analyzed to make sure it makes sense.